- Home
- LVLU vs OSTX Comparison
LVLU vs OSTX Comparison
Compare LVLU & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- OSTX
- Stock Information
- Founded
- LVLU 1996
- OSTX 2018
- Country
- LVLU United States
- OSTX United States
- Employees
- LVLU N/A
- OSTX N/A
- Industry
- LVLU Catalog/Specialty Distribution
- OSTX
- Sector
- LVLU Consumer Discretionary
- OSTX
- Exchange
- LVLU Nasdaq
- OSTX NYSE
- Market Cap
- LVLU 28.6M
- OSTX 36.2M
- IPO Year
- LVLU 2021
- OSTX 2024
- Fundamental
- Price
- LVLU $0.46
- OSTX $1.62
- Analyst Decision
- LVLU Hold
- OSTX Strong Buy
- Analyst Count
- LVLU 3
- OSTX 2
- Target Price
- LVLU $1.58
- OSTX $17.50
- AVG Volume (30 Days)
- LVLU 17.9K
- OSTX 2.2M
- Earning Date
- LVLU 03-27-2025
- OSTX 03-18-2025
- Dividend Yield
- LVLU N/A
- OSTX N/A
- EPS Growth
- LVLU N/A
- OSTX N/A
- EPS
- LVLU N/A
- OSTX N/A
- Revenue
- LVLU $324,699,000.00
- OSTX N/A
- Revenue This Year
- LVLU N/A
- OSTX N/A
- Revenue Next Year
- LVLU $1.72
- OSTX $26,663.99
- P/E Ratio
- LVLU N/A
- OSTX N/A
- Revenue Growth
- LVLU N/A
- OSTX N/A
- 52 Week Low
- LVLU $0.46
- OSTX $1.41
- 52 Week High
- LVLU $1.99
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- LVLU 11.81
- OSTX N/A
- Support Level
- LVLU $0.48
- OSTX N/A
- Resistance Level
- LVLU $0.77
- OSTX N/A
- Average True Range (ATR)
- LVLU 0.06
- OSTX 0.00
- MACD
- LVLU -0.02
- OSTX 0.00
- Stochastic Oscillator
- LVLU 3.46
- OSTX 0.00
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.